Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

Completed · Phase 1

Conditions studied: Bioequivalence Study

In brief

To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults

Key facts

Study ID

NCT04358770

Run by

Sun Pharmaceutical Industries, Inc.

People needed

124

Starts

2018-03-02

Expected to finish

2018-05-11

Last updated by the study team

2020-04-24

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Normal or clinically insignificant dermatological history the Screening visit and Day 1dosing;

You may not qualify if…

• Female subjects who were pregnant, nursing, or planning to become pregnant during study participation;
• History of hypersensitivity to the study products or any topical or systemic corticosteroids;

Where it is running

• WayCro — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.